Home > Drugs A-Z > Red Pepper

Red Pepper (Antigen Laboratories, Inc.)

Available Formats

Dosage Form Package Information Links
INJECTION, SOLUTION 5 mL in 1 VIAL, MULTI-DOSE (49288-0385-2) Label Information
INJECTION, SOLUTION 50 mL in 1 VIAL, MULTI-DOSE (49288-0385-5) Label Information
INJECTION, SOLUTION 2 mL in 1 VIAL, MULTI-DOSE (49288-0385-1) Label Information
INJECTION, SOLUTION 10 mL in 1 VIAL, MULTI-DOSE (49288-0385-3) Label Information
INJECTION, SOLUTION 30 mL in 1 VIAL, MULTI-DOSE (49288-0385-4) Label Information

Complete Red Pepper Information

  • BOXED WARNING(What is this?)

    WARNINGS

    Allergenic extract is intended for use by, or under the guidance of, physicians who are experienced in the administration of allergenic extracts for diagnosis and/or immunotherapy and the emergency care of anaphylaxis. This extract is not directly interchangeable with other allergenic extracts. The initial dose must be based on skin testing as described in the “DOSAGE AND ADMINISTRATION” section of this insert. Patients switching from other types of extracts to Antigen Laboratories’ allergenic extracts should be started as if they were undergoing treatment for the first time. Patients being switched from one lot of extract to another from the same manufacturer should have the dose reduced by 75%.

    Severe systemic reactions may occur with all allergenic extracts. In certain individuals, especially in steroid-dependent/unstable asthmatics, these life-threatening reactions may result in death. Patients should be observed for at least 20 minutes following allergenic extract injections. Treatment and emergency measures, as well as personnel trained in their use, must be available in the event of a life-threatening reaction. Sensitive patients may experience severe anaphylactic reactions resulting in respiratory obstruction, shock, coma and/or death. Report serious adverse events to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787, phone 1-800-FDA-1088.

    This product should not be injected intravenously. Deep subcutaneous routes have proven to be safe. See the “WARNINGS”, “PRECAUTIONS”, “ADVERSE REACTIONS” and “OVERDOSAGE” sections.

    Patients receiving beta-blockers may not be responsive to epinephrine or inhaled bronchodilators. Respiratory obstruction not responding to parenteral or inhaled bronchodilators may require theophylline, oxygen, intubation and the use of life support systems. Parenteral fluid and/or plasma expanders may be utilized for treatment of shock. Adrenocorticosteroids may be administered parenterally or intravenously. Refer to “WARNINGS”, “PRECAUTIONS” and “ADVERSE REACTIONS” sections below.


  • DESCRIPTION

    Antigen Laboratories’ allergenic extracts are manufactured from source material listed on the vial label. Lower concentrations (e.g. 1:50, 1:33, etc.) may be prepared either by dilution from a more concentrated stock or by direct extraction. The extract is a sterile solution containing extractables of source materials obtained from biological collecting and/or processing firms and Antigen Laboratories. All source materials are inspected by Antigen Laboratories’ technical personnel in accordance with 21 CFR 680.1 (b) (1). The route of administration for immunotherapy is subcutaneous. The routes of administration for diagnostic purposes are intradermal or prick-puncture of the skin.

    FOR ALLERGENIC EXTRACTS CONTAINING 50% V/V GLYCERINE AS PRESERVATIVE AND STABILIZER:

    INACTIVE INGREDIENTS:

    Sodium chloride…………………………………………………………….0.95%

    Sodium bicarbonate………………………………………………………..0.24%

    Glycerine…………………………………………………………………50% (v/v)

    Water for Injection…………………………………………………q.s. to volume

    Active allergens are described by common and scientific name on the stock concentrate container label or on last page of this circular.

    Food allergenic extracts may be manufactured on a weight/volume (w/v) or volume/volume (v/v) basis. Food extracts made from dried raw material are extracted at 2-10% (1:50-1:10 w/v ratio) in extracting fluid containing 50% glycerine. Slurries of juicy fruits or vegetables (prepared with a minimum amount of water for injection) are combined with an equal volume of glycerine for a ration of 1:1 volume/volume (v/v). Sodium chloride and sodium bicarbonate are added to the slurry and glycerine mixture. Fresh egg white extract is prepared by adding one part raw egg white to nine parts of extracting fluid (1:9 v/v).

    Antigen E is considered the most important allergen of Short Ragweed pollen and is used for the standardization of Short Ragweed allergenic extracts. Stock mixtures containing Short Ragweed are analyzed for Antigen E content by radial immunodiffusion using Center for Biologics Evaluation and Research (CBER) references and anti-serum. Antigen E content expressed as units of Antigen E per milliliter (U/ml) is printed on container label.


  • CLINICAL PHARMACOLOGY

    Studies indicate allergic individuals produce immunoglobulins of the IgE class in response to exposure to allergens. Subsequent exposure to the allergen results in a combination of allergen with IgE antibody fixed on mast cells or basophil membranes. This cross-linking results in stimulation of mast cell which leads to release and generation of pharmacologically active substances that produce immediate hypersensitivity reaction.3

    The mode of action of immunotherapy with allergenic extracts is still under investigation. Subcutaneous injections of increasing doses of allergenic extract into patients with allergic disease have been shown to result in both humoral and cellular changes including the production of allergen-specific IgG antibodies, the suppression of histamine release from target cells, decrease in circulating levels of antigen specific IgE antibody over long periods of time and suppression of peripheral blood T-lymphocyte cell responses to antigen.10, 14, 15


  • INDICATIONS AND USAGE

    Allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. Confirmation is determined by skin testing. Diagnostic use of allergenic extracts usually begins with direct skin testing. This product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing.


  • CONTRAINDICATIONS

    Do not administer in the presence of diseases characterized by bleeding diathesis. Individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. Patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. Children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.


  • WARNINGS

    Refer to boxed “WARNINGS”, “PRECAUTIONS”, “ADVERSE REACTIONS” and “OVERDOSAGE” sections for additional information on serious adverse reactions and steps to be taken, if any occur.

    Extreme caution is necessary when using diagnostic skin tests or injection treatment in highly sensitive patients who have experienced severe symptoms or anaphylaxis by natural exposure, or during previous skin testing or treatment. IN THESE CASES THE POTENCY FOR SKIN TESTS AND THE ESCALATION OF THE TREATMENT DOSE MUST BE ADJUSTED TO THE PATIENT’S SENSITIVITY AND TOLERANCE.

    Benefit versus risk needs to be evaluated in steroid dependent asthmatics, patients with unstable asthma or patients with underlying cardiovascular disease.

    Injections should never be given intravenously. A 5/8 inch, 25 gauge needle on a sterile syringe allows deep subcutaneous injection. Withdraw plunger slightly after inserting needle to determine if a blood vessel has been entered.

    Proper measurement of dose and caution in making injection will minimize reactions. Adverse reactions to allergenic extracts are usually apparent within 20-30 minutes following injection of immunotherapy.

    Extract should be temporarily withheld or dosage reduced in case of any of the following conditions: 1) flu or other infection with fever; 2) exposure to excessive amounts of allergen prior to injection; 3) rhinitis and/or asthma exhibiting severe symptoms; 4) adverse reaction to previous injection until cause of reaction has been evaluated by physician supervising patient’s immunotherapy program.


  • PRECAUTIONS

    General:

    Immunotherapy must be given under physician’s supervision. Sterile solutions, vials, syringes, etc. must be used. Aseptic technique must be observed in making dilutions from stock concentrates. The usual precautions in administering allergenic extracts are necessary, refer to boxed WARNINGS and “WARNINGS” section. Sterile syringe and needle must be used for each individual patient to prevent transmission of serum hepatitis, Human Immunodeficiency Virus (HIV) and other infectious agents.

    Epinephrine 1:1000 should be available. Refer to “OVERDOSAGE” section for description of treatment for anaphylactic reactions.

    Information for Patients:

    Patient should remain under observation of a nurse, physician, or personnel trained in emergency measures for at least 20 minutes following immunotherapy injection. Patient must be instructed to report any adverse reactions that occur within 24 hours after injection. Possible adverse reactions include unusual swelling and/or tenderness at injection site, rhinorrhea, sneezing, coughing, wheezing, shortness of breath, nausea, dizziness, or faintness. Immediate medical attention must be sought for reactions that occur during or after leaving physician’s office.

    Carcinogenesis, Mutagenesis, Impairment of Fertility:

    Long term studies in animals have not been conducted with allergenic extract to determine their potential for carcinogenicity, mutagenicity or impairment of fertility.

    Pregnancy Category C:

    Animal reproduction studies have not been conducted with allergenic extracts. It is not known whether allergenic extracts cause fetal harm during pregnancy or affect reproductive capacity. A systemic reaction to allergenic extract could cause uterine contractions leading to spontaneous abortion or premature labor. Allergenic extracts should be used during pregnancy only if potential benefit justifies potential risk to fetus.11

    Nursing Mothers:

    It is not known whether allergenic extracts are excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when allergenic extracts are administered to a nursing woman.

    Pediatric Use:

    Allergenic extracts have been used routinely in children, and no special safety problems or specific hazards have been found. Children can receive the same dose as adults. Discomfort is minimized by dividing the dose in half and administering injection at two different sites.16, 17

    Drug Interactions:

    Antihistamines. Antihistamines inhibit the wheal and flare reaction. The inhibitory effect of conventional antihistamines varies from 1 day up to 10 days, according to the drug and patient’s sensitivity. Long acting antihistamines (e.g., astemizole) may inhibit the wheal and flare for up to forty days.1, 2

    Imipramines, phenothiazines, and tranquilizers. Tricyclic antidepressants exert a potent and sustained decrease of skin reactions to histamine. This effect may last for a few weeks. Tranquilizers and antiemetic agents of the phenothiazine class have H1 antihistaminic activity and can block skin tests.1

    Corticosteroids. Short-term (less than 1 week) administration of corticosteroids at the therapeutic doses used in asthmatic patients does not modify the cutaneous reactivity to histamine, compound 48/80, or allergen. Long-term corticosteroid therapy modifies the skin texture and makes the interpretation of immediate skin tests more difficult.1

    Theophylline. It appears that theophylline need not be stopped prior to skin testing.1

    Beta-Blockers. Patients receiving beta-blockers may not be responsive to epinephrine or inhaled bronchodilators. The following are commonly prescribed beta-blockers: Levatol, Lopressor, Propanolol Intersol, Propanolol HCL, Blocadren, Propanolol, Inderal-LA, Visken, Corgard, Ipran, Tenormin, Timoptic. Ophthalmic beta-blockers: Betaxolol, Levobunolol, Timolol, Timoptic. Chemicals that are beta-blockers and may be components of other drugs: Acebutolol, Atenolol, Esmolol, Metoprolol, Nadolol, Penbutolol, Pindolol, Propanolol, Timolol, Labetalol, Carteolol.1

    Beta-adrenergic agents. Inhaled beta2 agonists in the usual doses used for the treatment of asthma do not usually inhibit allergen-induced skin tests. However, oral terbutaline and parenteral ephedrine were shown to decrease the allergen-induced wheal.1

    Cromolyn. Cromolyn inhaled or injected prior to skin tests with allergens or degranulating agents does not alter skin whealing response.1

    Other drugs. Other drugs have been shown to decrease skin test reactivity. Among them, dopamine is the best-documented compound.1

    Specific Immunotherapy. A decreased skin test reactivity has been observed in patients undergoing specific immunotherapy with pollen extracts, grass pollen allergoids, mites, hymenoptera venoms, or in professional beekeepers who are spontaneously desensitized. Finally, it was shown that specific immunotherapy in patients treated with ragweed pollen extract induced a decreased late-phase reaction.1


  • ADVERSE REACTIONS

    Adverse reactions include, but are not limited to urticaria; itching; edema of extremities; respiratory wheezing or asthma; dyspnea; cyanosis; tachycardia; lacrimation; marked perspiration; flushing of face, neck or upper chest; mild persistent clearing of throat; hacking cough or persistent sneezing.

    1) Local Reactions

    A mild burning immediately after injection is expected; this usually subsides in 10-20 seconds. Prolonged pain or pain radiating up arm is usually the result of intramuscular injection, making this injection route undesirable. Subcutaneous injection is the recommended route.

    Small amounts of erythema and swelling at the site of injection are common. Reactions should not be considered significant unless they persist for at least 24 hours or exceed 50 mm in diameter.

    Larger local reactions are not only uncomfortable, but indicate the possibility of a severe systemic reaction if dosage is increased. In such cases dosage should be reduced to the last level not causing reaction and maintained for two or three treatments before cautiously increasing.

    Large, persistent local reactions or minor exacerbations of the patient’s allergic symptoms may be treated by local cold applications and/or use of oral antihistamines.

    2) Systemic Reactions

    Systemic reactions range from mild exaggeration of patient’s allergic symptoms to anaphylactic reactions.14 Very sensitive patients may show a rapid response. It cannot be overemphasized that, under certain unpredictable combinations of circumstances, anaphylactic shock is always a possibility. Fatalities are rare but can occur.5 Other possible systemic reaction symptoms are fainting, pallor, bradycardia, hypotension, angioedema, cough, wheezing, conjunctivitis, rhinitis,and urticaria.13, 14

    Careful attention to dosage and administration limit such reactions. Allergenic extracts are highly potent to sensitive individuals and OVERDOSE could result in anaphylactic symptoms. Therefore, it is imperative that physicians administering allergenic extracts understand and prepare for treatment of severe reactions. Refer to “OVERDOSAGE” section.


  • OVERDOSAGE

    Refer to “WARNINGS”, “PRECAUTIONS” and “ADVERSE REACTIONS” sections for signs and symptoms of an overdose.

    If a systemic or anaphylactic reaction does occur, apply tourniquet above the site of allergenic extract injection and inject intramuscularly or subcutaneously 0.3 to 0.5 ml of 1:1000 Epinephrine-hydrochloride into the opposite arm or gluteal area. Repeat dose in 5-10 minutes if necessary. Loosen tourniquet briefly at 5 minute intervals to prevent circulatory impairment. Discontinue use of the tourniquet after ½ hour.

    The epinephrine HCL 1:1000 dose for infants to 2 years is 0.05 to 0.1 ml; for children 2 to 6 years it is 0.15 ml; for children 6 to 12 years it is 0.2 ml.

    Symptoms of progressive anaphylaxis include airway obstruction and/or vascular collapse. After administration of epinephrine, profound shock and vasomotor collapse should be treated with intravenous fluids and possibly vasoactive drugs. Monitor airways for obstruction. Oxygen should be given by mask if indicated.

    Antihistamines, H2 antagonist, bronchodilators, steroids and theophylline may be used as indicated after providing adequate epinephrine and circulatory support.4

    Patients who have been taking beta-blockers may be unresponsive to epinephrine. Epinephrine or beta-adrenergic drugs (Alupent) may be ineffective. These drugs should be administered even though a beta-blocker may have been taken. The following treatment will be effective whether or not patient is taking a beta-blocker: Aminophylline IV, slow push or drip, Atrovent (Ipratropium bromide) Inhaler, 3 inhalations repeated, Atropine, 0.4 mg/ml, 0.75 to 1.5 ml IM or IV, Solu-Cortef, 100-200 mg IM or IV, Solu-Medrol, 125 mg IM or IV, Glucagon, 0.5-1 mg IM or IV, Benadryl, 50 mg IM or IV, Cimetidine, 300 mg IM or IV, Oxygen via ambu bag.


  • DOSAGE AND ADMINISTRATION

    Refer to “STORAGE” section for proper storage condition for allergenic extract. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Some allergenic extracts naturally precipitate.

    Physicians undertaking immunotherapy should be concerned with patient’s degree of sensitivity. The initial dilution of allergenic extract, starting dose, and progression of dosage must be carefully determined on the basis of the patient’s history and results of skin tests. Strongly positive skin tests may be risk factors for systemic reactions. Less aggressive immunotherapy schedules may be indicated for such patients.

    Precaution is necessary when using extract mixture for skin testing. The diluting effect of individual components within a mixture may cause false negative reactions. Patients extremely sensitive to a common allergen in several components of a mixture may be more likely to experience a systemic reaction than when skin tested individually for each component.9

    PRICK-PUNCTURE TESTING: To identify highly sensitive individuals and as a safety precaution, it is recommended that a prick-puncture test using a drop of the extract concentrate be performed prior to initiating very dilute intradermal testing. Prick-puncture testing is performed by placing a drop of extract concentrate on the skin and puncturing the skin through the drop with a small needle such as a bifurcated vaccinating needle. The most satisfactory sites on the back for skin testing are from the posterior axillary fold to 2.5 cm from the spinal column, and from the top of the scapula to the lower rib margins. The best areas on the arms are the volar surfaces from the axilla to 2.5 or 5 cm above the wrist, skipping the anticubital space. A positive reaction is approximately 10-15 mm erythema with 2.5 mm wheal. Smaller, less conclusive reactions may be considered positive in conjunction with a definitive history of symptoms on exposure to the allergen. The more sensitive the patient the higher the probability that he/she will have symptoms related to the exposure of the offending allergen. Hence, the importance of a good patient history. Less sensitive individuals can be tested intradermally with an appropriately diluted extract.

    A positive control using histamine phosphate identifies patients whose skin may not react due to medications, metabolic or other reasons. A negative control (50% glycerine for prick-puncture testing) would exclude false-positive reactions due to ingredients in diluent or patients who have dermatographism.

    SINGLE DILUTION INTRADERMAL TESTING: The surface of the upper and lower arm is the usual location for skin testing. It is important that a new, sterile, disposable syringe and needle be used for each extract tested. Intracutaneous test dilutions, five-fold or ten-fold, may be prepared from stock concentrate using physiologic saline as a diluent. (1) Start testing with the most dilute allergenic extract concentration. (2) A volume of 0.02-0.05 ml should be injected slowly into the superficial skin layers making a small bleb (superficial wheal). (3) For patients without a history of extreme sensitivity, or a negative or weakly reactive prick-puncture test, the initial dilution for skin testing should be a dilution at least 1:12,500 w/v. This initial dilution can be prepared by diluting 1:20 to 1:50 w/v (2%-5%) extracts five-fold to 5-4 or 1:10 w/v (10%) extracts to 5-5. See “Serial Dilutions Titration Test Dilutions” chart on the next page. Dilute 1:10 w/v (10%) extracts to 10-3 if using ten-fold dilutions. (4) Sensitive patients with a positive prick-puncture test require a further dilution to at least 1:312,500 w/v. This dilution can be prepared by diluting 1:20 to 1:50 w/v (2% - 5%) extracts to 5-6 or 1:10 w/v (10%) extracts to 5-7 (five-fold dilutions). Ten-fold dilution to 10-6 of a 1:10 w/v (10%) extract would be a safe starting dilution. Size of reactions are quantitated based on size of wheal and erythema. For interpretation of skin reactions, refer to chart below. If after 20 minutes no skin reaction is observed, continue testing using increasing increments of the concentration until a reaction of 5-10 mm wheal and 11-30 mm erythema is obtained, or a concentration of 5-2 or 10-1 has been tested. A negative control, 50% glycerine diluted with diluent to 5-2 (1:25) or 10-1 (1:10) dilution and a positive control of histamine phosphate, should be tested and included in interpretation of skin reactions.1, 13

    GRADE mm ERYTHEMA mm WHEAL
    0 less than 5 less than 5
    ± 5-10 5-10
    1+ 11-20 5-10
    2+ 21-30 5-10
    3+ 31-40 10-15 or with pseudopods
    4+ greater than 40 greater than 15 or with many pseudopods

    INTRADERMAL TESTING-SKIN ENDPOINT TITRATION: The allergenic extracts to which the patient is sensitive, the patient’s degree of sensitivity and the dose of allergen to be used in immunotherapy can be determined through the use of intracutaneous skin tests involving progressive five-fold dilutions of allergenic extracts. Intracutaneously inject 0.01 to 0.02 ml of the test allergen to form a 4 mm diameter superficial skin wheal. For patients demonstrating a negative or weakly reactive prick-puncture skin test, an initial screening dilution of 1:12,500 w/v is safe. For patients demonstrating a positive prick-puncture skin test, an initial screening dilution of 1:312,500 w/v is safe. (See “Serial Dilution Titration Test Dilutions” chart below.) When a sequence of five-fold or ten-fold dilutions of an allergen are injected, the endpoint is determined by noting the dilution that first produces a wheal and erythema (15 minutes after injection) that is 2 mm larger than wheals with erythema produced by weaker, non-reacting dilutions (5 mm negative wheal). The endpoint dilution is used as a starting dose concentration for immunotherapy. An endpoint dose of 0.15 ml is a safe initial dose to be followed by escalation to the optimal maximum tolerated dose for each individual.

    Injections should never be given intravenously. A 5/8 inch, 25 gauge needle on a sterile syringe will allow deep subcutaneous injection.

    IMMUNOTHERAPY: If the first injection of the initial dilution of extract is tolerated without significant local reaction, increasing doses by 5-20% increments of that dilution may be administered. The rate of increase in dosage in the early stages of treatment with highly diluted extracts is usually more rapid than the rate of increase possible with more concentrated extracts. This schedule is intended only as a guide and must be modified according to the reactivity of the individual patient. Needless to say, the physician must proceed cautiously in the treatment of the highly sensitive patient who develops large local or systemic reactions.6

    Some patients may tolerate larger doses of the allergenic extract depending on patient response.7 Because diluted extract tends to lose activity in storage, the first dose from a more concentrated vial should be the same, or less than, the previous dose.8, 12

    Dosages progressively increase according to the tolerance of the patient at intervals of one to seven days until, (1) the patient achieves relief from symptoms, (2) induration at the site of injection is no larger than 50 mm in 36 to 48 hours, (3) a maintenance dose is reached (the largest dose tolerated by the patient that relieves symptoms without undesirable local or systemic reactions). This maintenance dose may be continued at regular intervals perennially. It may be necessary to adjust the progression of dosage downward to avoid local and constitutional reactions.

    The usual duration of treatment has not been established. A period of two or three years on immunotherapy constitutes an average minimum course of treatment.

    SERIAL DILUTION TITRATION TEST DILUTIONS APPROXIMATE ALLERGENIC EXTRACT CONCENTRATION RESULTING FROM 1:5 DILUTION
    Titration Number Dilution Exponent Weight / Volume Allergenic Extract Concentrate
    1:50 2% 1:40 2 1/2% 1:33 1/3 3% 1:20 5% 1:10 10%
    No. 1 5-1 1:5 1:250 1:200 1:167 1:100 1:50
    No. 2 5-2 1:25 1:1,250 1:1,000 1:835 1:500 1:250
    No. 3 5-3 1:125 1:6,250 1:5,000 1:4,175 1:2,500 1:1,250
    No. 4 5-4 1:625 1:31,250 1:25,000 1:20,875 1:12,500 1:6,250
    No. 5 5-5 1:3,125 1:156,250 1:125,000 1:104,375 1:62,500 1:31,250
    No. 6 5-6 1:15,625 1:781,250 1:625,000 1:521,875 1:312,500 1:156,250
    No. 7 5-7 1:78,125 1:3,906,250 1:3,125,000 1:2,609,375 1:1,562,500 1:781,250
    No. 8 5-8 1:390,625 1:19,531,250 1:15,625,000 1:13,046,875 1:7,812,500 1:3,906,250
    No. 9 5-9 1:1,953,125 1:97,656,250 1:78,125,000 1:65,234,375 1:39,062,500 1:19,531,250
    No. 10 5-10 1:9,765,625 1:488,281,250 1:390,625,000 1:326,171,875 1:195,312,500 1:97,656,250
    No. 11 5-11 1:48,828,125 1:2,441,406,250 1:1,953,125,000 1:1,630,859,375 1:976,562,500 1:488,281,250
    No. 12 5-12 1:244,140,625 1:12,207,031,250 1:9,765,625,000 1:8,154,296,875 1:4,882,812,500 1:2,441,406,250

  • HOW SUPPLIED

    Stock concentrates are available in concentrations of 2-10% or weight/volume (w/v) of 1:50, 1:33, 1:20 or 1:10. Some juicy or liquid foods are available at 1:1 volume/volume (v/v) extraction ratio. Fresh egg white extract is available at 1:9 v/v extraction ratio.

    Antigen E content of ragweed mixtures ranges from 46-166 U/ml for Ragweed Mixture (Short/Giant/Western/Southern Ragweed), 47-239 U/ml for Short/Giant/Western Ragweed Mixture, and 106-256 U/ml for Short/Giant Ragweed Mixture. Refer to container label for actual Antigen E content.

    Extract (stock concentrate) is supplied in 10, 30 and 50 ml containers. Extracts in 5 ml dropper bottles are available for prick-puncture testing. To insure maximum potency for the entire dating period, all stock concentrates contain 50% glycerine v/v.


  • STORAGE

    Store all stock concentrates and dilutions at 2-8° C. Keep at this temperature during office use. The expiration date of the allergenic extracts is listed on the container label. Dilutions of the allergenic extracts containing less than 50% glycerine are less stable. If loss of potency is suspected, potency can be checked using side by side skin testing with freshly prepared dilutions of equal concentration on individuals with known sensitivity to the allergen.


  • REFERENCES

    1. Bousquet, Jean: “In vivo methods for study of allergy: Skin tests” Third Edition, Allergy Principles and Practice, C.V. Mosby Co., Vol. I, Chap. 19, pp 419-436, 1988.

    2. Long, W.F., Taylor, R.J., Wagner, C.J., et al.: Skin test suppression by antihistamines and the development of subsensitivity, J. Allergy Clin. Immunol., pp. 76-113, 1985.

    3. Holgate, S.T., Robinson, C., Church, Mike: Mediators of Immediate Hypersensitivity, Third Edition, Allergy Principles and Practice, C.V. Mosby Co., Vol. I and II, pp 135-163, 1988.

    4. Wasserman, S., Marquart, D.: Anaphylaxis, Third Edition, Allergy Principles and Practice, C.V. Mosby Co., Vol. 1, Chap. 58, pp. 1365-1376, 1988.

    5. Reid, Michael J., Lockey, Richard F., Turkeltaub M.D., Paul C., Platts-Mills, Thomas. “Survey of Fatalities from Skin Testing and Immunotherapy 1985-1989”, Journal of Allergy and Clinical Immunology, Vol. 92, No. 1, pp. 6-15, 1993.

    6. Matthews, K., et al: Rhinitis, Asthma and Other Allergic Diseases. NIAID Task Force Report, U.S. Dept. HEW, NIH Publication No. 79-387, Chapter 4, pp. 213-217, May 1979.

    7. Ishizaka, K.: Control of IgE Synthesis, Third Edition, Allergy Principles and Practices, Vol. I, Chap. 4, p. 52, edited by Middleton et al.

    8. Nelson, H.S.: “The Effect of Preservatives and Dilution on the Deterioration of Russian Thistle (Salsola pestifer), a pollen extract.” The Journal of Allergy and Clinical Immunology, Vol. 63, No. 6, pp. 417-425, June 1979.

    9. Seebohm, P.M., et al: Panel on Review of Allergenic Extracts, Final Report, Food and Drug Administration, March 13, 1981, pp. 84-86.

    10. Rocklin, R.E., Sheffer, A.L., Grainader, D.K. and Melmon, K.: “Generation of antigen-specific suppressor cells during allergy desensitization”, New England Journal of Medicine, 302, May 29, 1980, pp. 1213-1219.

    11. Seebohm, P.M., et al: Panel on Review of Allergenic Extracts, Final Report, Food and Drug Administration, March 13, 1981, pp 9-48.

    12. Stevens, E.: Cutaneous Tests, Regulatory Control and Standardization of Allergenic Extracts, First International Paul-Ehrlich Seminar, May 20-22, 1979, Frankfurt, Germany, pp. 133-138.

    13. Van Metre, T., Adkinson, N., Amodio, F., Lichtenstein, L., Mardinay, M., Norman, P., Rosenberg, G., Sobotka, A., Valentine, M.: “A Comparative Study of the Effectiveness of the Rinkel Method and the Current Standard Method of Immunology for Ragweed Pollen Hay Fever,“ The Journal of Clinical Allergy and Immunology, Vol. 66, No. 6, p. 511, December 1980.

    14. Wasserman, S.: The Mast Cell and the Inflammatory Response. The Mast Cell-its role in Health and disease. Edited by J. Pepys & A.M. Edwards, Proceedings of an International Symposium, Davos, Switzerland, Pitman Medical Publishing Co., 1979, pp. 9-20.

    15. Perelmutter, L.: IgE Regulation During Immunotherapy of Allergic Diseases. Annals of Allergy, Vol. 57, August 1986.

    16. Bullock, J., Frick, O.: Mite Sensitivity in House Dust Allergic Children, Am. J. Dis. Child., pp. 123-222, 1972.

    17. Willoughby, J.W.: Inhalant Allergy Immunotherapy with Standardized and Nonstandardized Allergenic Extracts, American Academy of Otolaryngology-Head and Neck Surgery: Instructional Courses, Vol. 1, Chapter 15, C.V. Mosby Co., St. Louis, Missouri, September 1988.


  • CONTAINER LABELING

    5 mL Blue Label
    10 mL Blue Label
    30/50 mL Blue Label

  • INGREDIENTS AND APPEARANCE
    GREEN PEA 
    green pea injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0380
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PEA (UNII: W4X7H8GYFM) (PEA - UNII:W4X7H8GYFM) PEA 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0380-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0380-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0380-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0380-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0380-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BLACK-EYED PEA 
    black-eyed pea injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0381
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLACK-EYED PEA (UNII: 786YV7B602) (BLACK-EYED PEA - UNII:786YV7B602) BLACK-EYED PEA 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0381-1 1.0002 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0381-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0381-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0381-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0381-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    PEAR 
    pear injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0382
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PEAR (UNII: 2ZN8DWC0YF) (PEAR - UNII:2ZN8DWC0YF) PEAR 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0382-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0382-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0382-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0382-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0382-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    PARSLEY 
    parsley injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0377
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PARSLEY (UNII: 58FMD0Q0EV) (PARSLEY - UNII:58FMD0Q0EV) PARSLEY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0377-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0377-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0377-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0377-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0377-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    PEACH 
    peach injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0378
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PEACH (UNII: 3OKE88I3QG) (PEACH - UNII:3OKE88I3QG) PEACH 1 mL  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0378-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0378-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0378-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0378-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0378-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    PEANUT 
    peanut injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0379
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PEANUT (UNII: QE1QX6B99R) (PEANUT - UNII:QE1QX6B99R) PEANUT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0379-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0379-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0379-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0379-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0379-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    SWEET POTATO 
    sweet potato injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0388
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SWEET POTATO (UNII: M9WGG9Z9GK) (SWEET POTATO - UNII:M9WGG9Z9GK) SWEET POTATO 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0388-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0388-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0388-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0388-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0388-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    PUMPKIN 
    pumpkin injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0389
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PUMPKIN (UNII: SYW0QUB89Y) (PUMPKIN - UNII:SYW0QUB89Y) PUMPKIN 1 mL  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0389-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0389-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0389-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0389-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0389-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    PIMENTO 
    pimento injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0404
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RED BELL PEPPER (UNII: E917XHH50V) (RED BELL PEPPER - UNII:E917XHH50V) RED BELL PEPPER 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0404-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0404-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0404-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0404-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0404-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BLACK PEPPER 
    black pepper injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0384
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLACK PEPPER (UNII: KM66971LVF) (BLACK PEPPER - UNII:KM66971LVF) BLACK PEPPER 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0384-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0384-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0384-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0384-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0384-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    RED PEPPER 
    red pepper injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0385
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RED BELL PEPPER (UNII: E917XHH50V) (RED BELL PEPPER - UNII:E917XHH50V) RED BELL PEPPER 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0385-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0385-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0385-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0385-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0385-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    GREEN BELL PEPPER 
    green bell pepper injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0386
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GREEN BELL PEPPER (UNII: 4J4DOU3HEK) (GREEN BELL PEPPER - UNII:4J4DOU3HEK) GREEN BELL PEPPER 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0386-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0386-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0386-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0386-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0386-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    MUSHROOM 
    mushroom injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0305
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CULTIVATED MUSHROOM (UNII: 54C8E6W6JY) (CULTIVATED MUSHROOM - UNII:54C8E6W6JY) CULTIVATED MUSHROOM 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0305-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0305-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0305-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0305-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0305-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    MUSTARD SEED 
    mustard seed injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0306
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MUSTARD SEED (UNII: 58RXI817UT) (MUSTARD SEED - UNII:58RXI817UT) MUSTARD SEED 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0306-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0306-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0306-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0306-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0306-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    MUSTARD GREENS 
    mustard greens injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0316
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MUSTARD GREENS (UNII: 5M338IN22E) (MUSTARD GREENS - UNII:5M338IN22E) MUSTARD GREENS 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0316-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0316-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0316-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0316-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0316-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    HONEYDEW MELON 
    honeydew melon injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0300
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    HONEYDEW MELON (UNII: RN8P45F92A) (HONEYDEW MELON - UNII:RN8P45F92A) HONEYDEW MELON 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0300-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0300-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0300-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0300-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0300-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    MILLET 
    millet injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0303
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MILLET SEED (UNII: TJR6B3R47P) (MILLET SEED - UNII:TJR6B3R47P) MILLET SEED 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0303-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0303-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0303-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0303-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0303-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    MINT 
    mint injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0304
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SPEARMINT (UNII: J7I2T6IV1N) (SPEARMINT - UNII:J7I2T6IV1N) SPEARMINT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0304-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0304-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0304-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0304-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0304-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    NUTMEG 
    nutmeg injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0329
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    NUTMEG (UNII: AEE24M3MQ9) (NUTMEG - UNII:AEE24M3MQ9) NUTMEG 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0329-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0329-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0329-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0329-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0329-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    OLIVE 
    olive injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0345
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GREEN OLIVE (UNII: 6HD2W46UEG) (GREEN OLIVE - UNII:6HD2W46UEG) GREEN OLIVE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0345-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0345-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0345-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0345-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0345-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    POTATO 
    potato injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0374
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    POTATO (UNII: CFE1S8DYWD) (POTATO - UNII:CFE1S8DYWD) POTATO 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0374-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0374-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0374-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0374-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0374-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    PAPRIKA 
    paprika injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0376
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PAPRIKA (UNII: X72Z47861V) (PAPRIKA - UNII:X72Z47861V) PAPRIKA 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0376-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0376-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0376-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0376-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0376-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    ORANGE 
    orange injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0333
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ORANGE (UNII: 5EVU04N5QU) (ORANGE - UNII:5EVU04N5QU) ORANGE 1 mL  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0333-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0333-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0333-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0333-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0333-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    WHOLE GRAIN OAT 
    whole grain oat injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0334
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    OAT (UNII: Z6J799EAJK) (OAT - UNII:Z6J799EAJK) OAT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0334-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0334-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0334-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0334-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0334-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    ONION 
    onion injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0335
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ONION (UNII: 492225Q21H) (ONION - UNII:492225Q21H) ONION 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0335-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0335-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0335-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0335-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0335-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    PINEAPPLE 
    pineapple injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0405
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PINEAPPLE (UNII: 2A88ZO081O) (PINEAPPLE - UNII:2A88ZO081O) PINEAPPLE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0405-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0405-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0405-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0405-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0405-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    THYME 
    thyme injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0572
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GARDEN THYME (UNII: CW657OBU4N) (GARDEN THYME - UNII:CW657OBU4N) GARDEN THYME 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0572-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0572-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0572-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0572-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0572-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    VANILLA BEAN 
    vanilla bean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0591
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    VANILLA (UNII: Q74T35078H) (VANILLA - UNII:Q74T35078H) VANILLA 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0591-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0591-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0591-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0591-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0591-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    WHOLE WHEAT 
    whole wheat injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0595
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    WHEAT (UNII: 4J2I0SN84Y) (WHEAT - UNII:4J2I0SN84Y) WHEAT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0595-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0595-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0595-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0595-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0595-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    TOMATO 
    tomato injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0565
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TOMATO (UNII: Z4KHF2C175) (TOMATO - UNII:Z4KHF2C175) TOMATO 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0565-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0565-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0565-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0565-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0565-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    TAPIOCA 
    tapioca injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0566
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    STARCH, TAPIOCA (UNII: 24SC3U704I) (STARCH, TAPIOCA - UNII:24SC3U704I) STARCH, TAPIOCA 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0566-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0566-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0566-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0566-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0566-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    TURNIP 
    turnip injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0571
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    TURNIP (UNII: Z38C7FBM49) (TURNIP - UNII:Z38C7FBM49) TURNIP 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0571-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0571-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0571-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0571-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0571-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    ENGLISH WALNUT MEAT 
    english walnut meat injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0596
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ENGLISH WALNUT (UNII: 1V3SHR7QB7) (ENGLISH WALNUT - UNII:1V3SHR7QB7) ENGLISH WALNUT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0596-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0596-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0596-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0596-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0596-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    GRAPEFRUIT 
    grapefruit injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0223
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GRAPEFRUIT (UNII: O82C39RR8C) (GRAPEFRUIT - UNII:O82C39RR8C) GRAPEFRUIT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0223-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0223-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0223-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0223-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0223-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    PLUM 
    plum injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0407
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PLUM (UNII: 67M3EQ6BE1) (PLUM - UNII:67M3EQ6BE1) PLUM 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0407-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0407-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0407-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0407-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0407-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    RASPBERRY 
    raspberry injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0440
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RASPBERRY (UNII: 4N14V5R27W) (RASPBERRY - UNII:4N14V5R27W) RASPBERRY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0440-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0440-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0440-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0440-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0440-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BLACK WALNUT MEAT 
    black walnut meat injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0597
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLACK WALNUT (UNII: 02WM57RXZJ) (BLACK WALNUT - UNII:02WM57RXZJ) BLACK WALNUT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0597-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0597-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0597-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0597-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0597-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    WATERMELON 
    watermelon injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0598
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    WATERMELON (UNII: 231473QB6R) (WATERMELON - UNII:231473QB6R) WATERMELON 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0598-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0598-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0598-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0598-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0598-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BREWERS YEAST 
    brewers yeast injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0617
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SACCHAROMYCES CEREVISIAE (UNII: 978D8U419H) (SACCHAROMYCES CEREVISIAE - UNII:978D8U419H) SACCHAROMYCES CEREVISIAE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0617-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0617-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0617-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0617-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0617-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    RASPBERRY 
    raspberry injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0439
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RASPBERRY (UNII: 4N14V5R27W) (RASPBERRY - UNII:4N14V5R27W) RASPBERRY 1 mL  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0439-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0439-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0439-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0439-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0439-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    RICE 
    rice injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0441
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RICE (UNII: 659G217HPG) (RICE - UNII:659G217HPG) RICE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0441-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0441-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0441-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0441-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0441-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    RYE 
    rye injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0442
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RYE (UNII: 0R4AQI398X) (RYE - UNII:0R4AQI398X) RYE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0442-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0442-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0442-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0442-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0442-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    PLUM 
    plum injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0406
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PLUM (UNII: 67M3EQ6BE1) (PLUM - UNII:67M3EQ6BE1) PLUM 1 mL  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0406-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0406-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0406-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0406-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0406-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BAKERS YEAST 
    bakers yeast injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0429
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SACCHAROMYCES CEREVISIAE (UNII: 978D8U419H) (SACCHAROMYCES CEREVISIAE - UNII:978D8U419H) SACCHAROMYCES CEREVISIAE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0429-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0429-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0429-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0429-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0429-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    RADISH 
    radish injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0438
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RAPHANUS SATIVUS (UNII: 86R5J6D01D) (RAPHANUS SATIVUS - UNII:86R5J6D01D) RAPHANUS SATIVUS 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0438-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0438-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0438-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0438-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0438-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    SAFFLOWER SEED 
    safflower seed injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0474
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SAFFLOWER (UNII: 4VBL71TY4Y) (SAFFLOWER - UNII:4VBL71TY4Y) SAFFLOWER 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0474-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0474-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0474-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0474-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0474-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    SUGAR BEET 
    sugar beet injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0481
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BEET (UNII: N487KM8COK) (BEET - UNII:N487KM8COK) BEET 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0481-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0481-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0481-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0481-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0481-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    SUNFLOWER SEED 
    sunflower seed injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0483
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SUNFLOWER SEED (UNII: R9N3379M4Z) (SUNFLOWER SEED - UNII:R9N3379M4Z) SUNFLOWER SEED 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0483-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0483-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0483-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0483-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0483-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    SAGE 
    sage injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0493
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SALVIA OFFICINALIS (UNII: 065C5D077J) (SALVIA OFFICINALIS - UNII:065C5D077J) SALVIA OFFICINALIS 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0493-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0493-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0493-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0493-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0493-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    SESAME SEED 
    sesame seed injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0475
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SESAME SEED (UNII: 7Y1255HVXR) (SESAME SEED - UNII:7Y1255HVXR) SESAME SEED 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0475-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0475-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0475-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0475-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0475-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    SPINACH 
    spinach injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0479
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SPINACH (UNII: 6WO75C6WVB) (SPINACH - UNII:6WO75C6WVB) SPINACH 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0479-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0479-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0479-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0479-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0479-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    STRAWBERRY 
    strawberry injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0480
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    STRAWBERRY (UNII: 4J2TY8Y81V) (STRAWBERRY - UNII:4J2TY8Y81V) STRAWBERRY 1 mL  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0480-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0480-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0480-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0480-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0480-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    MALT 
    malt injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0292
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MALT EXTRACT, BARLEY (UNII: R3NBG8914U) (MALT EXTRACT, BARLEY - UNII:R3NBG8914U) MALT EXTRACT, BARLEY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0292-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0292-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0292-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0292-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0292-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BUCKWHEAT 
    buckwheat injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0051
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BUCKWHEAT (UNII: N0Y68724R3) (BUCKWHEAT - UNII:N0Y68724R3) BUCKWHEAT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0051-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0051-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0051-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0051-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0051-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BEET 
    beet injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0052
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BEET (UNII: N487KM8COK) (BEET - UNII:N487KM8COK) BEET 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0052-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0052-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0052-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0052-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0052-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BRAZIL NUT MEAT 
    brazil nut meat injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0053
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BRAZIL NUT (UNII: XKR79OET1K) (BRAZIL NUT - UNII:XKR79OET1K) BRAZIL NUT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0053-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0053-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0053-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0053-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0053-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    SOYBEAN 
    soybean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0048
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SOYBEAN (UNII: L7HT8F1ZOD) (SOYBEAN - UNII:L7HT8F1ZOD) SOYBEAN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0048-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0048-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0048-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0048-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0048-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BROCCOLI 
    broccoli injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0049
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BROCCOLI (UNII: UOI4FT57BZ) (BROCCOLI - UNII:UOI4FT57BZ) BROCCOLI 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0049-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0049-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0049-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0049-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0049-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BRUSSELS SPROUT 
    brussels sprout injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0050
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BRUSSELS SPROUT (UNII: KHX46H31F8) (BRUSSELS SPROUT - UNII:KHX46H31F8) BRUSSELS SPROUT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0050-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0050-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0050-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0050-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0050-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BLACKBERRY 
    blackberry injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0054
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLACKBERRY (UNII: 8A6OMU3I8L) (BLACKBERRY - UNII:8A6OMU3I8L) BLACKBERRY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0054-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0054-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0054-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0054-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0054-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CORN 
    corn injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0099
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CORN (UNII: 0N8672707O) (CORN - UNII:0N8672707O) CORN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0099-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0099-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0099-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0099-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0099-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CABBAGE 
    cabbage injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0101
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CABBAGE (UNII: GW0W1Y9I97) (CABBAGE - UNII:GW0W1Y9I97) CABBAGE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0101-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0101-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0101-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0101-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0101-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CANTALOUPE 
    cantaloupe injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0102
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CANTALOUPE (UNII: 8QF5D5H6UH) (CANTALOUPE - UNII:8QF5D5H6UH) CANTALOUPE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0102-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0102-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0102-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0102-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0102-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BLUEBERRY 
    blueberry injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0055
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BLUEBERRY (UNII: 253RUG1X1A) (BLUEBERRY - UNII:253RUG1X1A) BLUEBERRY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0055-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0055-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0055-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0055-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0055-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    KIDNEY BEAN 
    kidney bean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0061
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    KIDNEY BEAN (UNII: M98C8416QO) (KIDNEY BEAN - UNII:M98C8416QO) KIDNEY BEAN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0061-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0061-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0061-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0061-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0061-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BAY LEAF 
    bay leaf injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0071
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LAURUS NOBILIS (UNII: 247012Z29Q) (LAURUS NOBILIS - UNII:247012Z29Q) LAURUS NOBILIS 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0071-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0071-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0071-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0071-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0071-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    ASPARAGUS 
    asparagus injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0012
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ASPARAGUS (UNII: Z1EJP3037Z) (ASPARAGUS - UNII:Z1EJP3037Z) ASPARAGUS 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0012-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0012-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0012-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0012-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0012-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    AVOCADO 
    avocado injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0013
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    AVOCADO (UNII: SDS87L369F) (AVOCADO - UNII:SDS87L369F) AVOCADO 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0013-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0013-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0013-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0013-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0013-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BANANA 
    banana injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0040
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BANANA (UNII: 4AJZ4765R9) (BANANA - UNII:4AJZ4765R9) BANANA 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0040-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0040-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0040-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0040-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0040-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    ALMOND 
    almond injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0009
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ALMOND (UNII: 3Z252A2K9G) (ALMOND - UNII:3Z252A2K9G) ALMOND 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0009-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0009-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0009-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0009-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0009-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    APPLE 
    apple injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0010
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    APPLE (UNII: B423VGH5S9) (APPLE - UNII:B423VGH5S9) APPLE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0010-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0010-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0010-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0010-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0010-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    APRICOT 
    apricot injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0011
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    APRICOT (UNII: 269CJD5GZ9) (APRICOT - UNII:269CJD5GZ9) APRICOT 1 mL  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0011-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0011-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0011-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0011-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0011-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    BASIL 
    basil injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0041
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BASIL (UNII: 2U0KZP0FDW) (BASIL - UNII:2U0KZP0FDW) BASIL 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0041-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0041-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0041-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0041-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0041-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    NAVY BEAN 
    navy bean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0045
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    KIDNEY BEAN (UNII: M98C8416QO) (KIDNEY BEAN - UNII:M98C8416QO) KIDNEY BEAN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0045-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0045-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0045-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0045-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0045-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    PINTO BEAN 
    pinto bean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0046
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    KIDNEY BEAN (UNII: M98C8416QO) (KIDNEY BEAN - UNII:M98C8416QO) KIDNEY BEAN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0046-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0046-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0046-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0046-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0046-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    GREEN (STING) BEAN 
    green (string) bean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0047
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    STRING BEAN (UNII: N9D69B2Q7Y) (STRING BEAN - UNII:N9D69B2Q7Y) STRING BEAN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0047-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0047-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0047-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0047-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0047-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    WHOLE GRAIN BARLEY 
    whole grain barley injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0042
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    BARLEY (UNII: 5PWM7YLI7R) (BARLEY - UNII:5PWM7YLI7R) BARLEY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0042-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0042-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0042-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0042-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0042-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    LIMA BEAN 
    lima bean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0043
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LIMA BEAN (UNII: 112YH1ZMX2) (LIMA BEAN - UNII:112YH1ZMX2) LIMA BEAN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0043-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0043-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0043-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0043-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0043-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    MUNG BEAN 
    mung bean injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0044
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    MUNG BEAN (UNII: 1LIB31N73G) (MUNG BEAN - UNII:1LIB31N73G) MUNG BEAN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0044-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0044-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0044-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0044-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0044-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CARROT 
    carrot injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0104
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CARROT (UNII: L56Z1JK48B) (CARROT - UNII:L56Z1JK48B) CARROT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0104-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0104-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0104-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0104-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0104-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    GARLIC 
    garlic injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0218
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GARLIC (UNII: V1V998DC17) (GARLIC - UNII:V1V998DC17) GARLIC 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0218-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0218-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0218-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0218-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0218-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    GINGER 
    ginger injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0219
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GINGER (UNII: C5529G5JPQ) (GINGER - UNII:C5529G5JPQ) GINGER 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0219-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0219-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0219-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0219-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0219-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CONCORD GRAPE 
    concord grape injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0221
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CONCORD GRAPE (UNII: T3PW93IB4Q) (CONCORD GRAPE - UNII:T3PW93IB4Q) CONCORD GRAPE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0221-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0221-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0221-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0221-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0221-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    DILL SEED 
    dill seed injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0162
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DILL (UNII: Y05PC4JZRH) (DILL - UNII:Y05PC4JZRH) DILL 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0162-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0162-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0162-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0162-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0162-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/26/1974
    EGGPLANT 
    eggplant injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0196
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EGGPLANT (UNII: W5K7RAS4VK) (EGGPLANT - UNII:W5K7RAS4VK) EGGPLANT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0196-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0196-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0196-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0196-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0196-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    FILBERT NUT MEAT 
    filbert nut meat injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0199
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    HAZELNUT (UNII: IW0OM96F6O) (HAZELNUT - UNII:IW0OM96F6O) HAZELNUT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0199-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0199-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0199-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0199-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0199-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    GRAPEFRUIT 
    grapefruit injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0222
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    GRAPEFRUIT (UNII: O82C39RR8C) (GRAPEFRUIT - UNII:O82C39RR8C) GRAPEFRUIT 1 mL  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0222-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0222-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0222-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0222-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0222-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    LEMON 
    lemon injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0288
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LEMON (UNII: 24RS0A988O) (LEMON - UNII:24RS0A988O) LEMON 1 mL  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0288-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0288-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0288-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0288-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0288-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    LIME 
    lime injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0289
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LIME (CITRUS) (UNII: 8CZS546954) (LIME (CITRUS) - UNII:8CZS546954) LIME (CITRUS) 1 mL  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0289-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0289-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0289-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0289-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0289-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    LENTIL 
    lentil injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0290
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LENTIL (UNII: 6O38V6B52O) (LENTIL - UNII:6O38V6B52O) LENTIL 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0290-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0290-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0290-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0290-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0290-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    WHITE GRAPE 
    white grape injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0231
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    WINE GRAPE (UNII: 3GOV20705G) (WINE GRAPE - UNII:3GOV20705G) WINE GRAPE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0231-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0231-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0231-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0231-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0231-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    HOPS 
    hops injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0254
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    HOPS (UNII: 01G73H6H83) (HOPS - UNII:01G73H6H83) HOPS 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0254-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0254-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0254-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0254-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0254-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    LETTUCE 
    lettuce injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0286
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    LETTUCE (UNII: 5PO6NN3RRJ) (LETTUCE - UNII:5PO6NN3RRJ) LETTUCE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0286-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0286-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0286-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0286-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0286-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CHERRY 
    cherry injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0110
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    SWEET CHERRY (UNII: 93T4562ZI3) (SWEET CHERRY - UNII:93T4562ZI3) SWEET CHERRY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0110-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0110-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0110-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0110-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0110-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CLOVE 
    clove injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0112
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CLOVE (UNII: K48IKT5321) (CLOVE - UNII:K48IKT5321) CLOVE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0112-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0112-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0112-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0112-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0112-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CINNAMON 
    cinnamon injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0114
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CINNAMON (UNII: 5S29HWU6QB) (CINNAMON - UNII:5S29HWU6QB) CINNAMON 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0114-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0114-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0114-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0114-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0114-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CASHEW NUT MEAT 
    cashew nut meat injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0105
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CASHEW (UNII: 3H5U5CX7KO) (CASHEW - UNII:3H5U5CX7KO) CASHEW 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0105-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0105-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0105-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0105-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0105-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CAULIFLOWER 
    cauliflower injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0107
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CAULIFLOWER (UNII: 138LUT2DWV) (CAULIFLOWER - UNII:138LUT2DWV) CAULIFLOWER 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0107-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0107-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0107-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0107-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0107-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CELERY 
    celery injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0108
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CELERY (UNII: 44IDY6DTKX) (CELERY - UNII:44IDY6DTKX) CELERY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0108-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0108-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0108-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0108-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0108-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    WHOLE BEAN CACAO 
    whole bean cacao injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0115
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    COCOA BEAN (UNII: D9108TZ9KG) (COCOA BEAN - UNII:D9108TZ9KG) COCOA BEAN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0115-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0115-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0115-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0115-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0115-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CARAWAY SEED 
    caraway seed injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0152
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CARAWAY (UNII: W2FH8O2BBE) (CARAWAY - UNII:W2FH8O2BBE) CARAWAY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0152-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0152-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0152-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0152-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0152-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CUMIN 
    cumin injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0155
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CUMIN (UNII: AG9BNA51DQ) (CUMIN - UNII:AG9BNA51DQ) CUMIN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0155-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0155-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0155-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0155-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0155-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    DATE 
    date injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0161
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DATE (UNII: H3O7QI5HY7) (DATE - UNII:H3O7QI5HY7) DATE 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0161-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0161-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0161-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0161-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0161-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CRANBERRY 
    cranberry injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0117
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CRANBERRY (UNII: 0MVO31Q3QS) (CRANBERRY - UNII:0MVO31Q3QS) CRANBERRY 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0117-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0117-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0117-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0117-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0117-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    CUCUMBER 
    cucumber injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0118
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CUCUMBER (UNII: YY7C30VXJT) (CUCUMBER - UNII:YY7C30VXJT) CUCUMBER 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0118-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0118-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0118-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0118-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0118-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    COCONUT 
    coconut injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0120
    Route of Administration SUBCUTANEOUS, INTRADERMAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    COCONUT (UNII: 3RT3536DHY) (COCONUT - UNII:3RT3536DHY) COCONUT 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0120-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0120-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0120-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0120-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0120-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    PECAN NUT MEAT 
    pecan nut meat injection, solution
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49288-0383
    Route of Administration INTRADERMAL, SUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PECAN (UNII: F14P91GB5F) (PECAN - UNII:F14P91GB5F) PECAN 0.05 g  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    GLYCERIN (UNII: PDC6A3C0OX) 0.525 mL  in 1 mL
    SODIUM CHLORIDE (UNII: 451W47IQ8X) 0.0095 g  in 1 mL
    SODIUM BICARBONATE (UNII: 8MDF5V39QO) 0.0024 g  in 1 mL
    WATER (UNII: 059QF0KO0R)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:49288-0383-1 2 mL in 1 VIAL, MULTI-DOSE
    2 NDC:49288-0383-2 5 mL in 1 VIAL, MULTI-DOSE
    3 NDC:49288-0383-3 10 mL in 1 VIAL, MULTI-DOSE
    4 NDC:49288-0383-4 30 mL in 1 VIAL, MULTI-DOSE
    5 NDC:49288-0383-5 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    BLA BLA102223 03/23/1974
    Labeler - Antigen Laboratories, Inc. (030705628)
    Registrant - Antigen Laboratories, Inc. (030705628)
    Establishment
    Name Address ID/FEI Business Operations
    Antigen Laboratories, Inc. 030705628 manufacture